Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

KENILWORTH, N.J.--(BUSINESS WIRE)--With adverse drug events (ADEs) triggering an estimated 700,000 ED visits and 120,000 hospitalizations, RDx BioScience (RDx) points ...

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - Capecitabine and 5-FU are used for the treatment of colorectal, esophageal, stomach, ...

Susanne B. Haga ([email protected]) is an associate professor of medicine at the Duke University School of Medicine, in Durham, North Carolina. Ariel Kantor is an undergraduate research assistant at ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...

The struggles facing long-term care are numerous and well-documented. Providers, facilities, and families are constantly trying to find solutions to help improve patient care and staffing burdens.

Expert Rev Mol Diagn. 2012;12(8):841-855. From their experience with PGx testing, the authors believe that this clinical utility in primary care is possible. For instance, the authors recently ...

STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York ...

With the rapid advances in the field of genetics and growing understanding of the human brain and body, the past few decades have seen a rise in precision (or personalized) medicine. We know that ...

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc.